Neomedix Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-07-2024
- Paid Up Capital ₹ 1.38 M
as on 16-07-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.60 M
as on 16-07-2024
- Revenue 55.64%
(FY 2023)
- Profit 68.02%
(FY 2023)
- Ebitda 66.68%
(FY 2023)
- Net Worth 79.48%
(FY 2023)
- Total Assets 78.07%
(FY 2023)
About Neomedix Healthcare India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.38 M.
The company currently has active open charges totaling ₹0.60 M.
Parul Agarwal and Sanjeev Aggarwal serve as directors at the Company.
- CIN/LLPIN
U74999GJ2016PTC091754
- Company No.
091754
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Neomedix Healthcare India Private Limited offer?
Neomedix Healthcare India Private Limited offers a wide range of products and services, including Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at Neomedix Healthcare India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parul Agarwal  | Director | 30-Apr-2016 | Current |
| Sanjeev Aggarwal | Director | 30-Apr-2016 | Current |
Financial Performance and Corporate Structure Insights of Neomedix Healthcare India.
Neomedix Healthcare India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.64% increase. The company also saw a substantial improvement in profitability, with a 68.02% increase in profit. The company's net worth Soared by an impressive increase of 79.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neomedix Healthcare India?
In 2023, Neomedix Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Boxocean India Private Limited
Active 4 years 1 monthParul Agarwal and Sanjeev Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Mar 2021 | ₹0.60 M | Open |
How Many Employees Work at Neomedix Healthcare India?
Neomedix Healthcare India has a workforce of 84 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neomedix Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neomedix Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
